Search Results

There are 18187 results for: content related to: Effects of imatinib mesylate on the spontaneous activity generated by the guinea-pig prostate

  1. You have free access to this content
    Imatinib mesylate reduces production of extracellular matrix and prevents development of experimental dermal fibrosis

    Arthritis & Rheumatism

    Volume 56, Issue 1, January 2007, Pages: 311–322, Jörg H. W. Distler, Astrid Jüngel, Lars C. Huber, Ursula Schulze-Horsel, Jochen Zwerina, Renate E. Gay, Beat A. Michel, Thomas Hauser, Georg Schett, Steffen Gay and Oliver Distler

    Version of Record online : 28 DEC 2006, DOI: 10.1002/art.22314

  2. You have free access to this content
    Rare incidence of congestive heart failure in gastrointestinal stromal tumor and other sarcoma patients receiving imatinib mesylate


    Volume 116, Issue 1, 1 January 2010, Pages: 184–192, Jonathan C. Trent, Shalin S. Patel, Jianhu Zhang, Dejka M. Araujo, Juan-Carlos Plana, Daniel J. Lenihan, Dominic Fan, Shreyaskumar R. Patel, Robert S. Benjamin and Aarif Y. Khakoo

    Version of Record online : 2 NOV 2009, DOI: 10.1002/cncr.24683

  3. You have free access to this content
    Imatinib mesylate-sensitive blast crisis immediately after discontinuation of imatinib mesylate therapy in chronic myelogenous leukemia: Report of two cases

    American Journal of Hematology

    Volume 76, Issue 3, July 2004, Pages: 275–278, Takehiro Higashi, Junichi Tsukada, Chiaki Kato, Atsushi Iwashige, Takamitsu Mizobe, Shinichiro Machida, Hiroaki Morimoto, Ryosuke Ogawa, Yoko Toda and Yoshiya Tanaka

    Version of Record online : 22 JUN 2004, DOI: 10.1002/ajh.20096

  4. Intraoral hyperpigmentation due to imatinib mesylate. A review of the literature

    Oral Surgery

    Nilesh Pancholi and Pankaj Taneja

    Version of Record online : 15 OCT 2015, DOI: 10.1111/ors.12194

  5. Human hepatocyte assessment of imatinib drug–drug interactions – complexities in clinical translation

    British Journal of Clinical Pharmacology

    Volume 80, Issue 5, November 2015, Pages: 1097–1108, Jan H. Beumer, Venkateswaran C. Pillai, Robert A. Parise, Susan M. Christner, Brian F. Kiesel, Michelle A. Rudek and Raman Venkataramanan

    Version of Record online : 19 SEP 2015, DOI: 10.1111/bcp.12723

  6. You have free access to this content
    Platelet-derived growth factor receptor as a prognostic marker and a therapeutic target for imatinib mesylate therapy in osteosarcoma


    Volume 112, Issue 10, 15 May 2008, Pages: 2119–2129, Tadahiko Kubo, Sajida Piperdi, Jeremy Rosenblum, Cristina R. Antonescu, Wen Chen, Han-Soo Kim, Andrew G. Huvos, Rebecca Sowers, Paul A. Meyers, John H. Healey and Richard Gorlick

    Version of Record online : 13 MAR 2008, DOI: 10.1002/cncr.23437

  7. You have free access to this content
    Efficacy of imatinib mesylate for the treatment of locally advanced and/or metastatic tenosynovial giant cell tumor/pigmented villonodular synovitis


    Volume 118, Issue 6, 15 March 2012, Pages: 1649–1655, Philippe A. Cassier, Hans Gelderblom, Silvia Stacchiotti, David Thomas, Robert G. Maki, Judith R. Kroep, Winette T. van der Graaf, Antoine Italiano, Beatrice Seddon, Julien Dômont, Emanuelle Bompas, Andrew J. Wagner and Jean-Yves Blay

    Version of Record online : 5 AUG 2011, DOI: 10.1002/cncr.26409

  8. Proteomic strategy for probing complementary lethality of kinase inhibitors against pancreatic cancer


    Volume 13, Issue 23-24, December 2013, Pages: 3554–3562, Jin-Gyun Lee, Kimberly Q. McKinney, Jean-Luc Mougeot, Herbert L. Bonkovsky and Sun-Il Hwang

    Version of Record online : 25 NOV 2013, DOI: 10.1002/pmic.201300248

  9. You have free access to this content
    Imatinib mesylate treatment of nephrogenic systemic fibrosis

    Arthritis & Rheumatism

    Volume 58, Issue 8, August 2008, Pages: 2543–2548, Jonathan Kay and Whitney A. High

    Version of Record online : 30 JUL 2008, DOI: 10.1002/art.23696

  10. Anti-fibrotic activity and enhanced interleukin-6 production by hepatic stellate cells in response to imatinib mesylate

    Liver International

    Volume 32, Issue 6, July 2012, Pages: 1008–1017, Youngchul Kim, Maria I. Fiel, Efsevia Albanis, Hsin I. Chou, Weijia Zhang, Gregory Khitrov and Scott L. Friedman

    Version of Record online : 16 APR 2012, DOI: 10.1111/j.1478-3231.2012.02806.x

  11. Targeting PDGFR-β in Cholangiocarcinoma

    Liver International

    Volume 32, Issue 3, March 2012, Pages: 400–409, Christian D. Fingas, Joachim C. Mertens, Nataliya Razumilava, Steven F. Bronk, Alphonse E. Sirica and Gregory J. Gores

    Version of Record online : 2 DEC 2011, DOI: 10.1111/j.1478-3231.2011.02687.x

  12. Imatinib mesylate in children and adolescents with cancer

    Pediatric Blood & Cancer

    Volume 55, Issue 1, 15 July 2010, Pages: 18–25, Ronald D. Barr

    Version of Record online : 1 APR 2010, DOI: 10.1002/pbc.22484

  13. You have free access to this content
    Imatinib mesylate potentiates topotecan antitumor activity in rhabdomyosarcoma preclinical models

    International Journal of Cancer

    Volume 120, Issue 5, 1 March 2007, Pages: 1141–1149, Heather P. McDowell, Daniela Meco, Anna Riccardi, Barbara Tanno, Anna C. Berardi, Giuseppe Raschellà, Riccardo Riccardi and Carlo Dominici

    Version of Record online : 27 NOV 2006, DOI: 10.1002/ijc.22391

  14. Imatinib Mesylate, the First Molecularly Targeted Gene Suppressor

    Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy

    Volume 22, Issue 10, October 2002, Pages: 1249–1265, Vanita K. Pindolia and Barbara J. Zarowitz

    Version of Record online : 17 JAN 2012, DOI: 10.1592/phco.22.15.1249.33482

  15. Sarcoma and Gastrointestinal Stromal Tumors

    Gastrointestinal Oncology: A Critical Multidisciplinary Team Approach

    Markku Miettinen, Jerzy Lasota, Angela D. Levy, Heikki Joensuu, Ronald P. DeMatteo, Pages: 227–258, 2009

    Published Online : 14 JAN 2009, DOI: 10.1002/9781444300147.ch9

  16. Development of lichen sclerosus et atrophicus while receiving a therapeutic dose of imatinib mesylate for chronic myelogenous leukemia

    Journal of Cutaneous Pathology

    Volume 37, Issue 8, August 2010, Pages: 877–880, Hadas Skupsky, Rachel Abuav, Whitney High, Carolyn Pass and Gary Goldenberg

    Version of Record online : 23 AUG 2009, DOI: 10.1111/j.1600-0560.2009.01398.x

  17. Imatinib mesylate in scleroderma-associated diffuse skin fibrosis: a phase II multicentre randomized double-blinded controlled trial

    British Journal of Dermatology

    Volume 167, Issue 5, November 2012, Pages: 1138–1144, S. Prey, K. Ezzedine, A. Doussau, A.-S. Grandoulier, D. Barcat, E. Chatelus, E. Diot, C. Durant, E. Hachulla, J.-D. de Korwin-Krokowski, E. Kostrzewa, T. Quemeneur, C. Paul, T. Schaeverbeke, J. Seneschal, A. Solanilla, A. Sparsa, S. Bouchet, S. Lepreux, F.-X. Mahon, G. Chene and A. Taïeb

    Version of Record online : 5 OCT 2012, DOI: 10.1111/j.1365-2133.2012.11186.x

  18. Gastrointestinal Stromal Tumors

    Textbook of Uncommon Cancer

    Margaret von Mehren, Douglas B. Flieder, Chandrajit P. Raut, Pages: 465–483, 2012

    Published Online : 20 SEP 2012, DOI: 10.1002/9781118464557.ch33

  19. Current and Future Clinical Strategies in the Management of Chronic Myeloid Leukemia

    Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy

    Volume 30, Issue 9P2, September 2010, Pages: 77S–101S, Kamakshi V. Rao, Andrea Iannucci and Elias Jabbour

    Version of Record online : 6 JAN 2012, DOI: 10.1592/phco.30.pt2.77S

  20. Therapy of Advanced-Stage and Resistant Chronic Myeloid Leukemia

    Leukemias: Principles and Practice of Therapy

    Devendra K. Hiwase, Timothy P. Hughes, Pages: 281–295, 2011

    Published Online : 4 JAN 2011, DOI: 10.1002/9781444327359.ch23